Xtant Medical's Leadership to Participate in the CG 45th Annual Growth Conference

Xtant Medical's Attendance at the CG 45th Annual Growth Conference

On August 6, 2025, Xtant Medical Holdings, Inc. (traded under NYSE American: XTNT), announced its participation in the prestigious CG 45th Annual Growth Conference. This prominent event will take place on August 12, 2025, at 3:30 PM ET in Boston, Massachusetts. Representing the company will be CEO Sean Browne and CFO Scott Neils, who are set to engage in one-on-one meetings as well as present the company’s innovative solutions and future plans to conference attendees.

Xtant Medical is recognized globally as a leading medical technology firm. The company specializes in developing surgical solutions aimed at treating spinal, orthopedic, and wound care disorders. Their commitment to improving patient outcomes and supporting the gift of donation underlines the core of their operations. The upcoming conference presents a valuable opportunity for Xtant Medical to showcase its extensive portfolio, which includes a range of orthobiologics and spinal implant systems.

A Commitment to Innovation

Xtant Medical’s mission revolves around honoring organ donation and enhancing the lives of patients through innovative medical technologies. The company takes pride in its comprehensive offerings that cater to chronic and surgical wound care, as well as sports medicine markets. They are dedicated to maintaining the highest integrity and excellence in service, reflecting their deep commitment to both patients and healthcare providers.

As Browne and Neils prepare for the conference, they aim to highlight the company's latest advancements in medical technology. Presentations will focus not just on current products but also on the future trajectory that Xtant Medical aims to pursue in enhancing surgical solutions and improving patient care.

Corporate Strategy and Growth

The CG 45th Annual Growth Conference serves as a pivotal platform for Xtant Medical to connect with investors and healthcare stakeholders. Engaging in relevant discussions and networking is expected to foster beneficial relationships and collaborations that can drive the company's growth. Presentations will cover various aspects of the business, including recent financial outcomes, product development timelines, and strategic initiatives.

Moreover, Xtant Medical's presence at such an influential gathering signifies their proactive approach in seeking partnerships that can amplify their impact in the medical technology landscape. The conference promotes a culture of progressive thought leadership, making it an ideal venue for Xtant Medical to enhance its visibility and credibility in the industry.

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings specializes in the design, development, and commercialization of advanced surgical solutions. Alongside its notable spinal implant systems, the company emphasizes sustainability and ethical considerations in its operations. The commitment to improving healthcare outcomes through superior technology resonates strongly with the core values of Xtant Medical, allowing it to stand out in a competitive market.

With a team of dedicated professionals who are passionate about their work, Xtant Medical continues to push the boundaries of innovation in the medical field. As they prepare to showcase their developments at the CG 45th Annual Growth Conference, all eyes will be on them as a company that continually strives for excellence in medical technology.

To learn more about Xtant Medical’s mission and offerings, visit their website.